首页> 外国专利> METHOD OF REDUCING SPONTANEOUS AGGREGATION OF ERYTHROCYRES IN CASE OF STABLE STENOCARDIA OF 1-ST FUNCTIONAL CLASS AND ARTERIAL HYPERTENSION

METHOD OF REDUCING SPONTANEOUS AGGREGATION OF ERYTHROCYRES IN CASE OF STABLE STENOCARDIA OF 1-ST FUNCTIONAL CLASS AND ARTERIAL HYPERTENSION

机译:减少一阶功能类别和动脉高血压的稳定型角CAR的病例中减少红细胞自发聚集的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to hematology and cardiology and can be applied for reduction of spontaneous aggregation of erythrocytes (SAE) in case of stable stenocardia of I-II functional class (SS I-II FC) and arterial hypertension (AH). Substance of clamed method consists in the following: 2 month-long complex of hypolipodemic diet, dosed static and dynamic physical activities, which include morning hygienic gymnastics, medical-preventive gymnastics, separate physical activities during the day, daily swimming for not less than 30 min. per day in the middle of the day, intake of lisinopril in dose 10 mg 1 time per day in the morning and simvastatine 20 mg 1 time per day after meal.;EFFECT: combined application of all components allows normalising of SAE of patients with SS of I-II functional class and arterial hypertension due to exponentiation of their medical action during 2 months of treatment.
机译:技术领域本发明涉及医学,即涉及血液学和心脏病学,并且可以用于在I-II功能性类别(SS I-II FC)稳定的心动过速的情况下减少红细胞(SAE)的自发聚集。动脉高血压(AH)。固定方法的物质包括以下内容:低脂饮食2个月之久的复合物,进行静态和动态体育锻炼,包括早晨卫生体操,医学预防体操,白天单独进行体育锻炼,每天游泳不少于30次分钟每天中午每天服用10毫克赖诺普利,早晨每天1次,辛伐他汀20毫克,饭后每天1次。;效果:所有成分的联合应用可使SS患者的SAE正常化在治疗2个月期间因其医学作用的指数化而导致的I-II功能分类和高血压。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号